4.7 Article

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis

期刊

CELL DEATH & DISEASE
卷 13, 期 11, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41419-022-05409-0

关键词

-

资金

  1. National Natural Science Foundation of China [8190032307]
  2. Excellent Youth Foundation of Nanjing Scientific Committee [JQX20005]

向作者/读者索取更多资源

Glutamine metabolism and GDH enzyme play crucial roles in cell growth and cancer. The GDH inhibitor EGCG slows fibrosis progression, while SIRT4 protects the liver from fibrosis by inhibiting glutamate transformation.
Glutamine metabolism plays an essential role in cell growth, and glutamate dehydrogenase (GDH) is a key enzyme. GDH promotes the metabolism of glutamate and glutamine to generate ATP, which is profoundly increased in multiple human cancers. Through in vitro and in vivo experiments, we verified that the small-molecule GDH inhibitor EGCG slowed the progression of fibrosis by inhibiting GDH enzyme activity and glutamine metabolism. SIRT4 is a mitochondrial enzyme with NAD that promotes ADP ribosylation and downregulates GDH activity. The role of SIRT4 in liver fibrosis and the related mechanisms are unknown. In this study, we measured the expression of SIRT4 and found that it was downregulated in liver fibrosis. Modest overexpression of SIRT4 protected the liver from fibrosis by inhibiting the transformation of glutamate to 2-ketoglutaric acid (alpha-KG) in the tricarboxylic acid cycle (TCA), thereby reducing the proliferative activity of hepatic stellate cells (HSCs). Collectively, our study reveals that SIRT4 controls GDH enzyme activity and expression, targeting glutamine metabolism in HSCs and alleviating liver fibrosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据